4th Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$500,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S. 2260 -- EXPIRE Act of 2014 -- Issues Related to Tax Reform

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2260 (113th)

Defense DEF

DoD/TRICARE coverage of FDA-approved obesity medications H.R. 4435/S. 2410 -- National Defense Authorization bill for 2015 H.R. 4870 -- Department of Defense Appropriations Bill for 2015 (including H.R. 83 - Consolidated and Further Continuing Appropriations Act of FY15)

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4870 (113th), S. 2410 (113th), H.R. 4435 (113th), H.R. 83 (113th)

Medicare/Medicaid MMM

H.R. 2415/S. 1184 -- Treat and Reduce Obesity Act of 2013 -- Medicare Part D H.R. 2810 -- Medicare Patient Access and Quality Improvement Act of 2013 -- Medicare Part B and D patient access and choice H.R. 4302 Protecting Access to Medicare Act of 2014 (SGR Patch) - P.L. 113-93 -- Medicare Part B Patient Access

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1184 (113th), H.R. 2810 (113th), H.R. 4302 (113th), H.R. 2415 (113th)

Health Issues HCR

H.R. 3890/S. 1932 -- Better Care, Lower Cost Act Implementation issues related to the Pharmaceutical Quality, Security and Accountability Act (P.L. 113-54

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1932 (113th), H.R. 3890 (113th)

Budget/Appropriations BUD

H.R. 4870 -- Department of Defense Appropriations Act of 2015 -- DoD/TRICARE Issues HJ Res 124 -- Continuing Appropriations Resolution 2015 - DoD/TRICARE Issues, Medicare Issues (pharmaceutical reimbursement offsets, coverage of obesity Rx products) H.R. 83 -- Consolidated and Further Continuing Appropriations Act of 2015 (P.L. 113-235) -- Included FY 15 DoD Appropriations (DoD/TRICARE coverage of obesity drugs)

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4870 (113th), H.R. 83 (113th), H.J.Res. 124 (113th)

Pharmacy PHA

DEA Scheduling of Controlled Substances H.R. 4299 -- Improving Regulatory Transparency for New Medical Therapies Act S. 2862 -- Transparency, Patient Access and Effective Drug Enforcement Act of 2014

LobbyistCovered position, as disclosed
TIMOTHY CLARK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2862 (113th), H.R. 4299 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.